The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 10th 2025
Don’t be asleep at the wheel. AI is coming, and it’s coming fast.
Monday Pharmaceutical Mystery: What Is Causing an Outbreak of Parkinson Disease in Young People?
September 22nd 2020Seven cases of young people with stiffness throughout their body and an inability to speak presented to hospitals in different cities throughout the country, with seemingly no link between them.
Read More
Specialty Drug Pipeline Poised to Offer Many New Therapies in the Coming Year
September 21st 2020There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.
Read More
Scientists Predict COVID-19 to Become Seasonal Virus in Near Future
September 18th 2020The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.
Read More
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells You
September 16th 2020Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Read More
Managing Prescribing Rules, Implementing Real Time Verifications into Workflow During COVID-19
September 16th 2020The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
Read More
FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma
September 14th 2020The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Read More